Isomorphic Labs is a digital biology and drug discovery company using artificial intelligence to accelerate the design of new medicines. Building on AlphaFold and advanced machine learning, it develops predictive and generative models that help scientists understand biological systems, identify promising drug targets, design novel molecules and assess how potential therapies may perform. Its AI-first drug design engine supports work across multiple therapeutic areas and modalities, including small molecules and biologics. The company serves the pharmaceutical and biotechnology industries through internal drug programmes and research collaborations, aiming to make drug discovery faster, more precise and more scalable.
